Skip to content
1887

Abstract

is the dominant pathogen recovered from lung infection in people with cystic fibrosis. However, as an understudied pathogen there are knowledge gaps in relation to its population biology, phenotypic traits and useful model strains. A phylogenomic study of was undertaken using a total of 283 genomes, of which 73 were sequenced and 49 phenotypically characterized as part of this study. Average nucleotide identity analysis (ANI) and phylogenetic alignment of core genes demonstrated that the population separated into two distinct evolutionary clades, defined as lineage 1 (=58 genomes) and lineage 2 (=221 genomes). To examine the population biology of , a representative subgroup of 77 genomes (28 from the reference databases and the 49 novel short-read genome sequences) were selected based on multilocus sequence typing (MLST), isolation source and phylogenetic placement criteria. Comparative genomics was used to identify lineage-specific genes – in lineage 1 and in lineage 2 – and diagnostic PCRs targeting them were successfully developed. Phenotypic analysis of 49 representative strains showed considerable inter-strain variance, but the majority of the isolates tested were motile and capable of biofilm formation. A striking absence of protease activity was observed, but no lineage-specific phenotypic differences were demonstrated. Using phylogenomic and phenotypic criteria, three model CF strains were identified, BCC0084 (lineage 1), BCC1272 (lineage 2a) and BCC0033 lineage 2b, and their complete genome sequences determined. CF strains BCC0033 and BCC0084, and the environmental reference strain, ATCC 17616, were all capable of short-term survival within a murine lung infection model. By mapping the population biology, identifying lineage-specific PCRs and model strains, we provide much needed baseline resources for future studies of .

Funding
This study was supported by the:
  • Medical Research Council (Award MR/T030062/1)
    • Principal Award Recipient: ThomasR. Connor
  • Wellcome Trust (Award 204457/Z/16/Z)
    • Principal Award Recipient: DanielR. Neill
  • Cystic Fibrosis Foundation (Award MAHENT20G0)
    • Principal Award Recipient: EshwarMahenthiralingam
  • Cystic Fibrosis Trust (Award SRC 022)
    • Principal Award Recipient: EshwarMahenthiralingam
  • Medical Research Council (Award BV19101122)
    • Principal Award Recipient: KasiaM. Parfitt
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.001366
2023-08-01
2025-11-07

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/micro/169/8/mic001366.html?itemId=/content/journal/micro/10.1099/mic.0.001366&mimeType=html&fmt=ahah

References

  1. UK-Cystic-Fibrosis-Registry UK Cystic Fibrosis Registry 2020 Annual Data Report; 2021 https://www.cysticfibrosis.org.uk/sites/default/files/2022-05/2020%20Annual%20data%20report%20-%20Version%204.pdf
  2. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005; 3:144–156 [View Article] [PubMed]
    [Google Scholar]
  3. Ledson MJ, Gallagher MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998; 53:432–436 [View Article] [PubMed]
    [Google Scholar]
  4. Zlosnik JEA, Zhou G, Brant R, Henry DA, Hird TJ et al. Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years’ experience. Ann Am Thorac Soc 2015; 12:70–78 [View Article] [PubMed]
    [Google Scholar]
  5. Kenna DTD, Lilley D, Coward A, Martin K, Perry C et al. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J Med Microbiol 2017; 66:490–501 [View Article] [PubMed]
    [Google Scholar]
  6. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010; 23:299–323 [View Article] [PubMed]
    [Google Scholar]
  7. Aaron SD, Ferris W, Henry DA, Speert DP, Macdonald NE. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med 2000; 161:1206–1212 [View Article] [PubMed]
    [Google Scholar]
  8. Peeters C, Depoorter E, Praet J, Vandamme P. Extensive cultivation of soil and water samples yields various pathogens in patients with cystic fibrosis but not Burkholderia multivorans. J Cyst Fibros 2016; 15:769–775 [View Article] [PubMed]
    [Google Scholar]
  9. Drevinek P, Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 2010; 16:821–830 [View Article] [PubMed]
    [Google Scholar]
  10. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE et al. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000; 38:3165–3173 [View Article] [PubMed]
    [Google Scholar]
  11. Vandamme P, Holmes B, Coenye T, Goris J, Mahenthiralingam E et al. Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol 2003; 154:91–96 [View Article] [PubMed]
    [Google Scholar]
  12. Wallner A, King E, Ngonkeu ELM, Moulin L, Béna G. Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans. BMC Genomics 2019; 20:803 [View Article] [PubMed]
    [Google Scholar]
  13. Morales-Ruíz L-M, Rodríguez-Cisneros M, Kerber-Díaz J-C, Rojas-Rojas F-U, Ibarra JA et al. Burkholderia orbicola sp. nov., a novel species within the Burkholderia cepacia complex. Arch Microbiol 2022; 204:178 [View Article] [PubMed]
    [Google Scholar]
  14. Zlosnik JEA, Costa PS, Brant R, Mori PYB, Hird TJ et al. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am J Respir Crit Care Med 2011; 183:67–72 [View Article] [PubMed]
    [Google Scholar]
  15. Silva IN, Ferreira AS, Becker JD, Zlosnik JEA, Speert DP et al. Mucoid morphotype variation of Burkholderia multivorans during chronic cystic fibrosis lung infection is correlated with changes in metabolism, motility, biofilm formation and virulence. Microbiology 2011; 157:3124–3137 [View Article] [PubMed]
    [Google Scholar]
  16. Silva IN, Santos PM, Santos MR, Zlosnik JEA, Speert DP et al. Long-term evolution of Burkholderia multivorans during a chronic cystic fibrosis Infection reveals shifting forces of selection. mSystems 2016; 1:e00029-16 [View Article] [PubMed]
    [Google Scholar]
  17. Diaz Caballero J, Clark ST, Wang PW, Donaldson SL, Coburn B et al. A genome-wide association analysis reveals a potential role for recombination in the evolution of antimicrobial resistance in Burkholderia multivorans. PLoS Pathog 2018; 14:e1007453 [View Article] [PubMed]
    [Google Scholar]
  18. Peeters C, Cooper VS, Hatcher PJ, Verheyde B, Carlier A et al. Comparative genomics of Burkholderia multivorans, a ubiquitous pathogen with a highly conserved genomic structure. PLoS One 2017; 12:e0176191 [View Article] [PubMed]
    [Google Scholar]
  19. Bricio-Moreno L, Sheridan VH, Goodhead I, Armstrong S, Wong JKL et al. Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa. Nat Commun 2018; 9:2635 [View Article] [PubMed]
    [Google Scholar]
  20. Mullins AJ, Murray JAH, Bull MJ, Jenner M, Jones C et al. Genome mining identifies cepacin as a plant-protective metabolite of the biopesticidal bacterium Burkholderia ambifaria. Nat Microbiol 2019; 4:996–1005 [View Article] [PubMed]
    [Google Scholar]
  21. Jones C, Webster G, Mullins AJ, Jenner M, Bull MJ et al. Kill and cure: genomic phylogeny and bioactivity of Burkholderia gladioli bacteria capable of pathogenic and beneficial lifestyles. Microb Genom 2021; 7:mgen000515 [View Article] [PubMed]
    [Google Scholar]
  22. Baldwin A, Mahenthiralingam E, Drevinek P, Pope C, Waine DJ et al. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol 2008; 46:290–295 [View Article] [PubMed]
    [Google Scholar]
  23. Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MCJ et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005; 43:4665–4673 [View Article] [PubMed]
    [Google Scholar]
  24. Connor TR, Loman NJ, Thompson S, Smith A, Southgate J et al. CLIMB (the Cloud Infrastructure for Microbial Bioinformatics): an online resource for the medical microbiology community. Microb Genom 2016; 2:e000086 [View Article] [PubMed]
    [Google Scholar]
  25. Galore! KFT. Trim Galore!; 2017
  26. Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 2009; 17:10 [View Article]
    [Google Scholar]
  27. Andrews S. FastQC: a quality control tool for high throughput sequence data; 2009 https://www.bioinformatics.babraham.ac.uk/projects/fastqc/
  28. Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 2016; 32:3047–3048 [View Article] [PubMed]
    [Google Scholar]
  29. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 2017; 13:e1005595 [View Article] [PubMed]
    [Google Scholar]
  30. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012; 19:455–477 [View Article] [PubMed]
    [Google Scholar]
  31. Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 2014; 30:2068–2069 [View Article] [PubMed]
    [Google Scholar]
  32. Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol 2019; 20:257 [View Article] [PubMed]
    [Google Scholar]
  33. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 2013; 29:1072–1075 [View Article] [PubMed]
    [Google Scholar]
  34. Pritchard L. Pyani: python module for average nucleotide identity analyses; 2014
  35. Parks DH, Chuvochina M, Rinke C, Mussig AJ, Chaumeil P-A et al. GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy. Nucleic Acids Res 2022; 50:D785–D794 [View Article] [PubMed]
    [Google Scholar]
  36. Mullins AJ, Mahenthiralingam E. The hidden genomic diversity, specialized metabolite capacity, and revised taxonomy of Burkholderia sensu lato. Front Microbiol 2021; 12:726847 [View Article] [PubMed]
    [Google Scholar]
  37. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 2015; 31:3691–3693 [View Article] [PubMed]
    [Google Scholar]
  38. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol 2013; 30:772–780 [View Article] [PubMed]
    [Google Scholar]
  39. Stamatakis A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies. Bioinformatics 2014; 30:1312–1313 [View Article] [PubMed]
    [Google Scholar]
  40. Page AJ, Taylor B, Keane JA. Multilocus sequence typing by blast from de novo assemblies against PubMLST. J Open Source Softw 2016; 1:118 [View Article]
    [Google Scholar]
  41. Rashid MH, Kornberg A. Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci 2000; 97:4885–4890 [View Article] [PubMed]
    [Google Scholar]
  42. O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp 2011; 2011:47 [View Article] [PubMed]
    [Google Scholar]
  43. Kahm M, Hasenbrink G, Lichtenberg-Frate H, Ludwig J, Kschischo M. Grofit: Fitting biological growth curves. Nat Prec 2010 [View Article]
    [Google Scholar]
  44. R-Core-Team R: A Language and Environment for Statistical Computing Vienna, Austria: R Foundation for Statistical Computing; 2013
    [Google Scholar]
  45. Zlosnik JEA, Hird TJ, Fraenkel MC, Moreira LM, Henry DA et al. Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol 2008; 46:1470–1473 [View Article] [PubMed]
    [Google Scholar]
  46. Morris LS, Evans J, Marchesi JR. A robust plate assay for detection of extracellular microbial protease activity in metagenomic screens and pure cultures. J Microbiol Methods 2012; 91:144–146 [View Article] [PubMed]
    [Google Scholar]
  47. Mesureur J, Feliciano JR, Wagner N, Gomes MC, Zhang L et al. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog 2017; 13:e1006795 [View Article] [PubMed]
    [Google Scholar]
  48. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996; 34:2914–2920 [View Article] [PubMed]
    [Google Scholar]
  49. Brynildsrud O, Bohlin J, Scheffer L, Eldholm V. Rapid scoring of genes in microbial pan-genome-wide association studies with Scoary. Genome Biol 2016; 17:262 [View Article] [PubMed]
    [Google Scholar]
  50. Quinlan AR. BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Curr Protoc Bioinformatics 2014; 47:11 [View Article] [PubMed]
    [Google Scholar]
  51. Fothergill JL, Neill DR, Loman N, Winstanley C, Kadioglu A. Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs. Nat Commun 2014; 5:4780 [View Article] [PubMed]
    [Google Scholar]
  52. Green AE, Howarth D, Chaguza C, Echlin H, Langendonk RF et al. Pneumococcal colonization and virulence factors identified via experimental evolution in infection models. Mol Biol Evol 2021; 38:2209–2226 [View Article] [PubMed]
    [Google Scholar]
  53. Seemann T. Snippy: fast bacterial variant calling from NGS reads; 2018 https://github.com/tseemann/snippy
  54. Richter M, Rosselló-Móra R. Shifting the genomic gold standard for the prokaryotic species definition. Proc Natl Acad Sci 2009; 106:19126–19131 [View Article] [PubMed]
    [Google Scholar]
  55. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res 2018; 3:124 [View Article] [PubMed]
    [Google Scholar]
  56. Caraher E, Duff C, Mullen T, Mc Keon S, Murphy P et al. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. J Cyst Fibros 2007; 6:49–56 [View Article] [PubMed]
    [Google Scholar]
  57. Freschi L, Vincent AT, Jeukens J, Emond-Rheault J-G, Kukavica-Ibrulj I et al. The Pseudomonas aeruginosa pan-genome provides new insights on its population structure, horizontal gene transfer, and pathogenicity. Genome Biol Evol 2019; 11:109–120 [View Article] [PubMed]
    [Google Scholar]
  58. Weiser R, Green AE, Bull MJ, Cunningham-Oakes E, Jolley KA et al. Not all Pseudomonas aeruginosa are equal: strains from industrial sources possess uniquely large multireplicon genomes. Microb Genom 2019; 5:e000276 [View Article] [PubMed]
    [Google Scholar]
  59. Gingues S, Kooi C, Visser MB, Subsin B, Sokol PA. Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol 2005; 187:8247–8255 [View Article] [PubMed]
    [Google Scholar]
  60. Rau MH, Hansen SK, Johansen HK, Thomsen LE, Workman CT et al. Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. Environ Microbiol 2010; 12:1643–1658 [View Article] [PubMed]
    [Google Scholar]
  61. Mahenthiralingam E, Campbell ME, Speert DP. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 1994; 62:596–605 [View Article] [PubMed]
    [Google Scholar]
  62. Zlosnik JEA, Mori PY, To D, Leung J, Hird TJ et al. Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis. PLoS One 2014; 9:e106428 [View Article] [PubMed]
    [Google Scholar]
  63. Kalferstova L, Kolar M, Fila L, Vavrova J, Drevinek P. Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis?. J Clin Microbiol 2015; 53:1515–1522 [View Article] [PubMed]
    [Google Scholar]
  64. Coutinho CP, Dos Santos SC, Madeira A, Mira NP, Moreira AS. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Inf Microbio 2011; 1:12 [View Article]
    [Google Scholar]
/content/journal/micro/10.1099/mic.0.001366
Loading
/content/journal/micro/10.1099/mic.0.001366
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error